We are live on ! Find out more
PCM

Parsons Capital Management Portfolio holdings

AUM $2.21B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+12.76%
1 Year Est. Return
+28.12%
3 Year Est. Return
+84.89%
5 Year Est. Return
+106.02%
10 Year Est. Return
+395.61%
AUM
$996M
AUM Growth
+$73M
Cap. Flow
-$4.39M
Cap. Flow %
-0.44%
Top 10 Hldgs %
32.34%
Holding
361
New
17
Increased
88
Reduced
159
Closed
12

Top Buys

Rank Stock Value
1
RLMD icon
Relmada Therapeutics
RLMD
+$11.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.4M
3
TFC icon
Truist Financial
TFC
+$2.17M
4
FENY icon
Fidelity MSCI Energy Index ETF
FENY
+$1.55M
5
IBM icon
IBM
IBM
+$1.33M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$6.06M
2
MMM icon
3M
MMM
+$6.04M
3
STI
SunTrust Banks, Inc.
STI
+$2.12M
4
STZ icon
Constellation Brands
STZ
+$1.69M
5
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$1.45M

Sector Composition

Rank Sector Weight
1 Technology 19.34%
2 Healthcare 13.59%
3 Financials 12.59%
4 Industrials 12.28%
5 Consumer Discretionary 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.54T
$90.9M 9.13%
1,238,140
-3,700
-0.3% -$238K
MMM icon
2
3M
MMM
$90.9B
$62.1M 6.24%
421,241
-43,125
-9% -$6.04M
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.1T
$33.8M 3.4%
149,411
-672
-0.4% -$146K
AMZN icon
4
Amazon
AMZN
$2.92T
$24M 2.41%
259,600
+3,380
+1% +$299K
MSFT icon
5
Microsoft
MSFT
$3.45T
$23.7M 2.38%
150,359
-2,092
-1% -$307K
JPM icon
6
JPMorgan Chase
JPM
$935B
$20.1M 2.02%
144,222
-321
-0.2% -$41.2K
XOM icon
7
ExxonMobil
XOM
$644B
$20M 2.01%
286,559
-5,753
-2% -$398K
JNJ icon
8
Johnson & Johnson
JNJ
$618B
$18.3M 1.83%
125,172
+128
+0.1% +$17.4K
CMCSA icon
9
Comcast
CMCSA
$85B
$14.5M 1.46%
323,239
+4,200
+1% +$187K
PG icon
10
Procter & Gamble
PG
$336B
$14.5M 1.46%
116,308
+1,246
+1% +$152K
RLMD icon
11
Relmada Therapeutics
RLMD
$557M
$14.3M 1.44%
+366,933
New +$11.1M
AMT icon
12
American Tower
AMT
$80.8B
$12.8M 1.29%
55,837
-185
-0.3% -$40.3K
INTC icon
13
Intel
INTC
$455B
$12.7M 1.27%
211,945
-1,889
-0.9% -$106K
DIS icon
14
Walt Disney
DIS
$167B
$11.7M 1.18%
81,029
+1,862
+2% +$260K
TMO icon
15
Thermo Fisher Scientific
TMO
$213B
$11.7M 1.17%
35,878
-171
-0.5% -$51.9K
HON icon
16
Honeywell
HON
$77B
$10.9M 1.09%
65,086
-276
-0.4% -$45.1K
HD icon
17
Home Depot
HD
$331B
$10.5M 1.05%
47,869
+460
+1% +$104K
VOO icon
18
Vanguard S&P 500 ETF
VOO
$979B
$10.4M 1.04%
34,994
+82
+0.2% +$23.2K
CVX icon
19
Chevron
CVX
$392B
$10.1M 1.01%
83,669
-1,445
-2% -$170K
MRK icon
20
Merck
MRK
$322B
$9.23M 0.93%
106,385
-707
-0.7% -$58.1K
GOOGL icon
21
Alphabet (Google) Class A
GOOGL
$4.36T
$9.11M 0.92%
136,040
-780
-0.6% -$50.3K
ABT icon
22
Abbott
ABT
$183B
$8.87M 0.89%
102,118
-1,295
-1% -$108K
NEE icon
23
NextEra Energy
NEE
$181B
$8.8M 0.88%
145,432
-2,884
-2% -$168K
IVV icon
24
iShares Core S&P 500 ETF
IVV
$878B
$8.79M 0.88%
27,180
-763
-3% -$236K
BA icon
25
Boeing
BA
$171B
$8.65M 0.87%
26,551
-1,891
-7% -$669K
1
2 3 4 5

Similar funds

WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
NLGIA
Nippon Life Global Investors Americas New York $2.22B AUM 30.05% 1-Year Est. Return
ML
McAdam LLC Philadelphia, Pennsylvania $2.22B AUM 16.98% 1-Year Est. Return
IFA
Index Fund Advisors Irvine, California $2.22B AUM 20.66% 1-Year Est. Return
DPCM
Darlington Partners Capital Management Greenbrae, California $2.23B AUM 16.2% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.23B AUM 15% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM

Parsons Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Parsons Capital Management held 361 positions worth $996M, up 7.9% from $923M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parsons Capital Management's Q4 2019 filing shows 17 new, 88 increased, 159 reduced and 12 closed positions. Its largest new stake was Relmada Therapeutics: 366,933 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $6.06M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Parsons Capital Management's largest Q4 2019 buy was Relmada Therapeutics: 366,933 shares worth $14.3M.
  • Parsons Capital Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.4M increase.
  • Parsons Capital Management's biggest Q4 2019 reduction was 3M, cutting an estimated $6.04M.
  • Parsons Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $6.06M.
  • Parsons Capital Management's ten largest holdings make up 32% of its $996M portfolio in Q4 2019.
  • Parsons Capital Management opened 17 new positions and closed 12 in Q4 2019.
  • Parsons Capital Management's portfolio value rose 7.9% quarter-over-quarter to $996M.

Based on Parsons Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.